OrthoPediatrics (KIDS) Investor Presentation - Slideshow

Financial Performance & Growth - OrthoPediatrics Corp achieved record sales of $22.2 million in Q3 2020, a 7% increase year-over-year [13] - US sales grew strongly by 17% year-over-year in Q3 2020 [14] - FY19 revenue reached $72.6 million, representing a 26% increase [4] - The company has demonstrated consistent growth of 20+% since its inception [4, 43] - The company's gross margin was 75% in FY 2019 [42] Market & Product Strategy - The company targets a large and focused market with a $1.4 billion U.S and $3.2 billion global addressable market in 2019 [4, 24] - Trauma & Deformity accounted for 68% of 2019 revenue [25] - Scoliosis accounted for 30% of 2019 revenue [25] - Sports Medicine/Other accounted for 2% of 2019 revenue [25] Acquisitions & Technology - The acquisition of Vilex and its Orthex Hexapod system cost $60 million, with a net investment of $35 million after the divestiture of adult assets [35] - ApiFix was acquired for 934,768 shares of common stock and $2 million in cash, plus milestone payments and an earnout [37]